For the data from India and Cameroon, the data is deposited in our institutional repository, and are freely available: <http://datacompass.lshtm.ac.uk/>. The DOI for the two datasets is: DOI: [10.17037/DATA.116](https://doi.org/10.17037/DATA.116). For the data from Guatemala and Nepal, the data underlying this study cannot be made publicly available, as approval was not obtained from study participants to make their data openly available due to legal and ethical restrictions imposed by the national board of Guatemala and Nepal. Researchers interested in the data may contact Islay Mactaggart at the Guatemala National Study (email: <islay.mactaggart@lshtm.ac.uk>) or the International Centre for Evidence in Disability (email: <disabilitycentre@lshtm.ac.uk>) for data access. For the data from the Maldives, this is openly available and uploaded to the LSHTM Data Compass: <https://doi.org/10.17037/DATA.00001698>.

Introduction {#sec004}
============

Disability is an umbrella term, including people, covering functional difficulties (impairments), activity limitations, and participation restrictions, inclusive of mental health conditions \[[@pone.0231563.ref001]\]. The World Health Organization's 2011 Global Report on Disability estimates that 15% of people experience significant functioning difficulties in their everyday lives \[[@pone.0231563.ref001]\]. However, people with disabilities may experience functional difficulties in multiple domains. Indeed, it is well-established that poor physical health can have a deleterious effect on other aspects of a person's wellbeing \[[@pone.0231563.ref002]--[@pone.0231563.ref004]\], and that people with physical and/or sensory functional difficulties are at higher risk of mental health conditions, including anxiety and depression \[[@pone.0231563.ref005], [@pone.0231563.ref006]\]. For instance, studies across the globe have demonstrated that people with visual impairment are more likely to experience depression \[[@pone.0231563.ref007], [@pone.0231563.ref008]\], and there appears to be a dose-response relationship with more severe visual impairment linked to a higher prevalence of depression \[[@pone.0231563.ref009]\]. People with physical impairments or hearing loss are also more likely to report poorer mental health, including depression \[[@pone.0231563.ref003], [@pone.0231563.ref010]--[@pone.0231563.ref014]\]. The likely pathway for these associations is that people with sensory or physical impairments experience difficulties in activities and functioning, which have consequences for reduced perceived control, lower social connectedness, and worse financial circumstances, which all increase the risk of depression and other mental health conditions \[[@pone.0231563.ref002], [@pone.0231563.ref015]--[@pone.0231563.ref017]\]. The presence of pain may also contribute to the link between impairments with depression, for instance among people with functional difficulties \[[@pone.0231563.ref018], [@pone.0231563.ref019]\].

The higher prevalence of depression and other mental health conditions in people with other types of disabilities is an important issue. First, as already described, approximately 15% of people experience significant functioning difficulties in their everyday lives \[[@pone.0231563.ref001]\]. Furthermore, people with impairments who experience depression have lower quality of life than those without these mental health impacts \[[@pone.0231563.ref020]\]. The association of physical/sensory functional difficulties with depression and anxiety has implications for advocacy and service planning. Rather than viewing psychosocial and other impairments in isolation, it is vital to understand these interactions and support people holistically, although this will require scaling up of mental health services, particularly in LMICs \[[@pone.0231563.ref021]\]. It is also important to identify factors that are associated with an increased risk of poor mental health among people with other types of disabilities to inform areas for intervention.

However, there are important gaps in knowledge on the link between physical and sensory functional difficulties and poor mental health. There has been little work to compare how different functional limitations (e.g. hearing, vision, or physical) are associated with anxiety and depression, even though these relationships are likely to vary. Moreover, most studies in the existing evidence base have focussed on the link of depression with functional limitations, rather than anxiety \[[@pone.0231563.ref003]\]. Another gap is that data from LMICs is sparse \[[@pone.0231563.ref005], [@pone.0231563.ref013]\], and often does not distinguish between types of functional limitations \[[@pone.0231563.ref022], [@pone.0231563.ref023]\]. There are also concerns that existing studies may be prone to bias, and variations between studies in the ways in which mental and physical conditions are measured makes it difficult to compare data across settings \[[@pone.0231563.ref006]\].

In this study, we aimed to assess the association between anxiety and depression and physical and sensory (vision or hearing) functional difficulties, among adults living in LMICs, using data from five population-based surveys. This secondary data analysis was undertaken to support a better understanding of the comorbidity between mental health and other impairments, and therefore promote better integrated health services.

Materials and methods {#sec005}
=====================

Population-based surveys {#sec006}
------------------------

This study uses data from five cross-sectional surveys undertaken between 2011 and 2017 in five LMICs: Cameroon, Guatemala, Maldives, India and Nepal ([Table 1](#pone.0231563.t001){ref-type="table"}) \[[@pone.0231563.ref024]--[@pone.0231563.ref026]\]. Three were regional/district level surveys, while two (Guatemala, Maldives) were national surveys. All surveys used population-based sampling, and the response rates ranged between 82% and 95%. While the original surveys included children, our analyses are restricted to adults ≥18 years. Individuals (or representatives if unable to self-report) were asked a series of questions, of which the reported Washington Group Extended Question Set on Functioning ([Box 1](#pone.0231563.box001){ref-type="boxed-text"}) formed part. The Washington Group Questions are a validated and widely used tool to screen for functional difficulties \[[@pone.0231563.ref027]\].

10.1371/journal.pone.0231563.t001

###### Survey participants (≥18 years).

![](pone.0231563.t001){#pone.0231563.t001g}

                                                                Nepal           Guatemala        India                                         Cameroon                                     Maldives
  ------------------------------------------------------------- --------------- ---------------- --------------------------------------------- -------------------------------------------- ----------------------
  Place, date                                                   Tanahun, 2016   National, 2016   Mahbubnagar District, Telengana State, 2014   Fundong Health District (North West), 2013   National, 2017
  Size (response rate %[\*](#t001fn001){ref-type="table-fn"})   4,067 (95%)     7,604 (88%)      2,349 (88%)                                   1,617 (87%)                                  3,700 (82%)
  Average age (years), range                                    43.0 (18--96)   39.2 (18--100)   39.2 (18--98)                                 44.5 years (18--99)                          39.3 years (18--102)
  \% Female                                                     57.7%           57.0%            54.3% (1,277)                                 69.8% (1,129)                                57.5% (2,147)
  \% Rural[^α^](#t001fn002){ref-type="table-fn"}                73.1%           58.2%            Not available                                 Not available                                61.5%

\*Response rate was for the whole survey whereas everything else is quoted for adults only.

^α^ Defined as outside of the capital Male' for the Maldives.

### Box 1. Relevant Washington Group Extended Question Set on Functioning Questions (source: Washington group on disability statistics \[[@pone.0231563.ref009]\]) {#sec007}

VISION

1.  Do you wear glasses? (Yes/No)

2.  If yes, do you have difficulty seeing even when wearing your glasses? (No difficulty / Some difficulty /A lot of difficulty /Cannot do at all or unable to do).

3.  If no, do you have difficulty seeing? (No difficulty / Some difficulty /A lot of difficulty /Cannot do at all or unable to do).

HEARING

4.  Do you wear a hearing aid? (Yes/No)

5.  If yes, do you have difficulty hearing even when using a hearing aid? (No difficulty / Some difficulty /A lot of difficulty /Cannot do at all or unable to do).

6.  If no, do you have difficulty hearing? (No difficulty / Some difficulty /A lot of difficulty /Cannot do at all or unable to do).

MOBILITY

7.  Do you use any equipment or receive help for getting around? (Yes/No)

8.  If yes, Do you have difficulty walking or climbing steps, even when using your equipment or with help? (No difficulty / Some difficulty /A lot of difficulty /Cannot do at all or unable to do).

9.  Do you have difficulty walking or climbing steps? (No difficulty / Some difficulty /A lot of difficulty /Cannot do at all or unable to do).

OR (For Guatemala only)

10. Do you have difficulty walking or climbing steps? (No difficulty / Some difficulty /A lot of difficulty /Cannot do at all or unable to do)

11. Do you use any equipment or receive help for getting around? (Yes/No)

ANXIETY

12. How often do you feel worried, nervous or anxious? (Daily/ Weekly/ Monthly/ A few times a year/ Never)

13. Do you take medication for these feelings? (Yes/No) (Not Nepal)

14. Thinking about the last time you felt worried, nervous or anxious, how would you describe the level of these feelings? (A little/ A lot/ Somewhere in between a little and a lot).

DEPRESSION

15. How often do you feel depressed? (Daily/ Weekly/ Monthly/ A few times a year/ Never)

16. Do you take medication for these feelings? (Yes/No) (Not Nepal)

17. Thinking about the last time you felt depressed, how would you describe the level of these feelings? (A little/ A lot/ Somewhere in between a little and a lot).

Classification of functional difficulty {#sec008}
---------------------------------------

[Box 1](#pone.0231563.box001){ref-type="boxed-text"} details the Washington group questions that were used in this study. Individuals were classed as having a functional difficulty (vision, hearing or mobility) if they answered 'a lot of difficulty' or 'cannot do at all'/'unable to do' to the relevant question, and no difficulty if they answered 'none' or 'some'. This classification was based on their function 'with aid' (i.e glasses, hearing aids or mobility devices) if the individual reported use of aids, and 'without aid' if no use of aids was reported. There were some small variations in the questions used, for example in the Guatemala study the mobility question was not dependent on using an aid. Our hypothesis is that functional difficulty may lead to poor mental health. Consequently, the remaining questions from the Washington Group Short Set, on understanding, self-care and communication, were not included in our analyses as these are potentially consequences of poor mental health.

Classification of anxiety and depression {#sec009}
----------------------------------------

There are two questions used to classify each of anxiety and depression ([Box 1](#pone.0231563.box001){ref-type="boxed-text"}) which asked about frequency and severity of symptoms; only individuals who answered daily, weekly, monthly or a few times a year were then asked about severity. The more recent 'Washington Group Anxiety and Depression' (WG AD) definition was used to classify individuals as severe, moderate, mild/none for anxiety and depression rather than the original 'Washington Group Extended Set-Functioning' (WG ES-F) classification ([Fig 1](#pone.0231563.g001){ref-type="fig"}) \[[@pone.0231563.ref028]\]. When there was missing data, we used responses for the frequency question to determine the anxiety and depression level where there was only one classification possible (see [Fig 1C](#pone.0231563.g001){ref-type="fig"}. WG AD measure, adapted for this paper).

![Anxiety and depression classification using Washington Group Questions (source: Washington Group Mental Health Work Group Update \[[@pone.0231563.ref028]\]).](pone.0231563.g001){#pone.0231563.g001}

Statistical analysis {#sec010}
--------------------

Stata 15 was used for statistical analysis. Multivariable logistic regression was undertaken to assess the association between each of the three domains of functional difficulty (vision, hearing, mobility) with anxiety and depression, separately for each data set. The regression analyses were adjusted for age group (18--44, 45--65 and 65+ groups) and sex. A small number of participants had missing data for individual functioning questions, and these responses were retained and used within the data analysis where possible.

Ethics and consent {#sec011}
------------------

Each survey received separate approval from the London School of Hygiene & Tropical Medicine and from local ethics committees \[[@pone.0231563.ref024]--[@pone.0231563.ref026]\]. Written (signed or fingerprint) informed consent was obtained from all subjects.

Results {#sec012}
=======

A total of 19,337 adults (age 18+ years) were included in the analysis; the largest survey was Guatemala (7,604) and the smallest was Cameroon (1,617). The prevalence of functional difficulty varied between the five surveys by domain: hearing (report 'cannot do' or 'a lot' of difficulty) ranged between 1.0% and 3.5%, visual 0.7% to 3.6% and mobility 2.0% to 5.5% ([Table 2](#pone.0231563.t002){ref-type="table"}). Hearing aids were rare in all settings (0.1% to 0.6% of the whole surveyed population of adults), while glasses (6.3% to 35.7%) and mobility aids (2.2% to 16.1%) were much more common ([S1 Table](#pone.0231563.s001){ref-type="supplementary-material"}).

10.1371/journal.pone.0231563.t002

###### Prevalence of different domains of functional difficulty.

![](pone.0231563.t002){#pone.0231563.t002g}

                                                      Nepal                Guatemala            India                Cameroon[^\$^](#t002fn002){ref-type="table-fn"}   Maldives             
  --------------------------------------------------- -------------------- -------------------- -------------------- ------------------------------------------------- -------------------- -------
  **Hearing**[\*](#t002fn001){ref-type="table-fn"}                                                                                                                                          
  "A lot or more"                                     n                    53                   120                  86                                                33                   36
  \% (95% CI)                                         1.3% (1.0--1.7)      1.6% (1.3--1.9)      3.7% (3.0--4.5)      2.0% (1.5--2.9)                                   1.0% (0.7--1.3)      
  **Visual**[\*](#t002fn001){ref-type="table-fn"}                                                                                                                                           
  "A lot or more"                                     n                    27                   240                  85                                                48                   86
  \% (95% CI)                                         0.7% (0.5--1.0)      3.2% (2.8--3.6)      3.6% (2.9--4.5%)     3.0% (2.3--3.9)                                   2.3% (1.9--2.9%)     
  **Mobility**[\*](#t002fn001){ref-type="table-fn"}                                                                                                                                         
  "A lot or more"                                     n                    83                   214                  111                                               88                   166
  \% (95% CI)                                         2.0% (1.6--2.5)      2.8% (2.5--3.2)      4.7% (3.9--5.7)      5.5% (4.5--6.7)                                   4.5% (3.9--5.2)      
  **Anxiety**                                                                                                                                                                               
  Severe                                              n                    47                   466                  181                                               94                   304
  \% (95% CI)                                         1.2% (0.9--1.6)      6.1% (5.6--6.7)      7.8% (6.7--8.9)      5.9% (4.8--7.1)                                   8.2% (7.4--9.1)      
  Moderate                                            n                    175                  1,610                457                                               410                  208
  \% (95% CI)                                         4.4% (3.8--5.1)      21.2% (20.2--22.1)   19.6% (18.0--21.3)   25.6% (23.5--27.8)                                5.6% (4.9--6.4)      
  Mild/None                                           n                    3,760                5,525                1,694                                             1,097                3,188
  \% (95% CI)                                         94.4% (93.7--95.1)   72.7% (71.7--73.7)   72.6% (70.8--74.4)   68.5% (66.2--70.8)                                86.2% (85.0--87.2)   
  **Depression**                                                                                                                                                                            
  Severe                                              n                    35                   236                  141                                               75                   244
  \% (95% CI)                                         0.9% (0.6--1.2)      3.1% (2.7--3.5)      6.1% (5.2--7.1)      4.8% (3.9--6.0)                                   6.6% (5.8--7.4)      
  Moderate                                            n                    195                  991                  376                                               299                  162
  \% (95% CI)                                         4.9% (4.3--5.6)      13.0% (12.3--13.8)   16.2% (14.7--17.7)   19.3% (17.4--21.3)                                4.4% (3.8--5.1)      
  Mild/None                                           n                    3,746                6,371                1,811                                             1,177                3,294
  \% (95% CI)                                         94.2% (93.4--94.9)   83.9% (83.0--84.7)   77.8% (76.1--79.4)   75.9% (73.7--78.0)                                89.0% (88.0--90.0)   

\*Available correction or assistance (i.e. reported using hearing aids, glasses, or walking aids if the respondent has these aids).

^\$^1 individual answered 'don't know' for hearing, and 1 individual for mobility.

Severe anxiety ranged from 1.2% prevalence in Nepal to 8.2% in the Maldives, while moderate levels were between 4.4% (Nepal) and 25.6% (Cameroon) ([Table 2](#pone.0231563.t002){ref-type="table"}). Depression prevalence showed the same pattern; it was lowest again in Nepal (severe 0.9%, moderate 4.9%) and highest in the Maldives for severe depression (6.6%) and in Cameroon for moderate (19.3%). Across the settings, few participants were taking medication for anxiety (from 0.9% of the whole surveyed population of adults in India, to 9.5% in Guatemala), or depression (0.6% to 3.1%) ([S1 Table](#pone.0231563.s001){ref-type="supplementary-material"}).

Tables [3](#pone.0231563.t003){ref-type="table"}, [4](#pone.0231563.t004){ref-type="table"} and [5](#pone.0231563.t005){ref-type="table"} show the prevalence of high, medium and low/no anxiety and depression by type of functional difficulty. Self-reported anxiety and depression prevalence were highest in Guatemala for all functional difficulty types, and lowest in Nepal (vision and mobility) and Cameroon (hearing). For all countries except Nepal and the Maldives, individuals reporting mobility difficulties were found to have the highest prevalence of severe anxiety and depression.

10.1371/journal.pone.0231563.t003

###### Association between anxiety and depression and functional difficulties in hearing[\*](#t003fn001){ref-type="table-fn"}.

![](pone.0231563.t003){#pone.0231563.t003g}

                    People with hearing functional difficulties (a lot or cannot do)   People without hearing functional difficulties (no difficulty/some difficulty)   OR (95% CI) adjusted for age and sex   P-value
  ----------------- ------------------------------------------------------------------ -------------------------------------------------------------------------------- -------------------------------------- ---------
  **Nepal**         **N = 48**                                                         **N = 3,934**                                                                    **N = 3,982**                          
  Anxiety                                                                                                                                                                                                      
      • Severe      10.4%                                                              1.1%                                                                             9.6 (3.5, 26.6)                        \<0.001
      • Moderate    10.4%                                                              4.3%                                                                             2.4 (0.9, 6.2)                         0.08
      • Mild/None   79.2%                                                              94.6%                                                                            Baseline                               
  Depression                                                                                                                                                                                                   
      • Severe      8.5%                                                               0.8%                                                                             11.7 (3.8, 36.5)                       \<0.001
      • Moderate    21.3%                                                              4.7%                                                                             4.9 (2.3, 10.2)                        \<0.001
      • Mild/None   70.2%                                                              94.5%                                                                            Baseline                               
  **Guatemala**     **n = 120**                                                        **n = 7,481**                                                                    **n = 7,600**                          
  Anxiety                                                                                                                                                                                                      
      • Severe      25.0%                                                              5.8%                                                                             4.9 (3.1, 7.8)                         \<0.001
      • Moderate    22.5%                                                              21.2%                                                                            1.5 (0.9, 2.3)                         0.11
      • Mild/None   52.5%                                                              73.0%                                                                            Baseline                               
  Depression                                                                                                                                                                                                   
      • Severe      20.0%                                                              2.8%                                                                             6.3 (3.8, 10.4),                       \<0.001
      • Moderate    14.2%                                                              13.0%                                                                            1.3 (0.7, 2.2)                         0.38
      • Mild/None   65.8%                                                              84.1%                                                                            Baseline                               
  **India**         n = 85                                                             n = 2,247                                                                        n = 2,332                              
  Anxiety                                                                                                                                                                                                      
      • Severe      15.3%                                                              7.5%                                                                             1.7 (0.9, 3.2)                         0.12
      • Moderate    21.2%                                                              19.5%                                                                            1.0 (0.6, 1.7)                         0.90
      • Mild/None   63.5%                                                              73.0%                                                                            Baseline                               
  Depression                                                                                                                                                                                                   
      • Severe      13.4%                                                              5.8%                                                                             1.9 (0.9, 3.8)                         0.07
      • Moderate    18.3%                                                              16.1%                                                                            1.0 (0.6, 1.8)                         0.97
      • Mild/None   68.3%                                                              78.1%                                                                            Baseline                               
  **Cameroon**      n = 32                                                             n = 1,567                                                                        n = 1,599                              
  Anxiety                                                                                                                                                                                                      
      • Severe      9.4%                                                               5.8%                                                                             1.4 (0.4, 5.0)                         0.56
      • Moderate    25.0%                                                              25.7%                                                                            1.1 (0.5, 2.5)                         0.84
      • Mild/None   65.6%                                                              68.5%                                                                            Baseline                               
  Depression                                                                                                                                                                                                   
      • Severe      6.5%                                                               4.8%                                                                             0.9 (0.2, 4.2)                         0.94
      • Moderate    16.1%                                                              19.4%                                                                            0.8 (0.3--2.2)                         0.71
      • Mild/None   77.4%                                                              75.8%                                                                            Baseline                               
  **Maldives**      n = 36                                                             n = 3,664                                                                        n = 3,700                              
  Anxiety                                                                                                                                                                                                      
      • Severe      22.2%                                                              8.1%                                                                             2.8 (1.2--6.5)                         0.02
      • Moderate    2.8%                                                               5.7%                                                                             0.5 (0.1--4.2)                         0.56
      • Mild/None   75.0%                                                              86.3%                                                                            Baseline                               
  Depression                                                                                                                                                                                                   
      • Severe      13.9%                                                              6.5%                                                                             2.1 (0.8--5.7)                         0.15
      • Moderate    5.6%                                                               4.4%                                                                             1.7 (0.4--7.5)                         0.50
      • Mild/None   80.6%                                                              89.1%                                                                            Baseline                               

\* There were some missing data for depression variables: 3--5 people within Nepal, Guatemala, and India across cases and controls, and 1 case and 49 controls in Cameroon.

10.1371/journal.pone.0231563.t004

###### Association between anxiety and depression and functional difficulties in vision[\*](#t004fn001){ref-type="table-fn"}.

![](pone.0231563.t004){#pone.0231563.t004g}

                    People with visual functional difficulties (a lot or cannot do)   People without visual functional difficulties (no difficulty/ some difficulty)   OR (95% CI) adjusted for age and sex   p-value
  ----------------- ----------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------- ---------
  **Nepal**         **n = 24**                                                        **n = 3,958**                                                                    **n = 3,982**                          
  Anxiety                                                                                                                                                                                                     
      • Severe      8.3%                                                              1.1%                                                                             7.8 (1.7, 35.5)                        0.01
      • Moderate    20.8%                                                             4.3%                                                                             5.4 (1.9, 15.1)                        0.001
      • Mild/None   70.1%                                                             94.6%                                                                            Baseline                               
  Depression                                                                                                                                                                                                  
      • Severe      8.7%                                                              0.8%                                                                             13.8 (2.9, 65.6)                       0.001
      • Moderate    34.8%                                                             4.7%                                                                             10.1 (4.0, 25.2)                       \<0.001
      • Mild/None   56.5%                                                             94.4%                                                                            Baseline                               
  **Guatemala**     **n = 240**                                                       **n = 7,361**                                                                    **n = 7,600**                          
  Anxiety                                                                                                                                                                                                     
      • Severe      30.4%                                                             5.3%                                                                             8.8 (6.3, 12.2)                        \<0.001
      • Moderate    27.1%                                                             21.0%                                                                            2.2 (1.6, 3.0)                         \<0.001
      • Mild/None   42.5%                                                             73.7%                                                                            Baseline                               
  Depression                                                                                                                                                                                                  
      • Severe      20.4%                                                             2.5%                                                                             9.3 (6.4, 13.6)                        \<0.001
      • Moderate    22.5%                                                             12.7%                                                                            2.4 (1.7, 3.4)                         \<0.001
      • Mild/None   57.1%                                                             84.7%                                                                            Baseline                               
  **India**         **n = 84**                                                        **n = 2,246**                                                                    **n = 2,330**                          
  Anxiety                                                                                                                                                                                                     
      • Severe      16.7%                                                             7.4%                                                                             2.0 (1.1, 3.9)                         0.03
      • Moderate    27.4%                                                             19.3%                                                                            1.3 (0.8, 2.3)                         0.28
      • Mild/None   56.0%                                                             73.3%                                                                            Baseline                               
  Depression                                                                                                                                                                                                  
      • Severe      17.9%                                                             5.6%                                                                             3.2 (1.7, 6.1)                         \<0.001
      • Moderate    25.0%                                                             15.8%                                                                            1.7 (1.0, 3.0)                         0.05
      • Mild/None   57.1%                                                             78.6%                                                                            Baseline                               
  **Cameroon**      **n = 48**                                                        **n = 1,544**                                                                    **n = 1,592**                          
  Anxiety                                                                                                                                                                                                     
      • Severe      14.6%                                                             5.6%                                                                             2.6 (1.1, 6.4)                         0.04
      • Moderate    25.0%                                                             25.5%                                                                            1.2 (0.6, 2.4)                         0.62
      • Mild/None   60.4%                                                             68.9%                                                                            Baseline                               
  Depression                                                                                                                                                                                                  
      • Severe      20.0%                                                             5.9%                                                                             3.4 (1.5, 7.5)                         0.004
      • Moderate    17.8%                                                             17.7%                                                                            1.2 (0.5, 2.8)                         0.599
      • Mild/None   62.2%                                                             76.4%                                                                            Baseline                               
  **Maldives**      **n = 86**                                                        **n = 3,614**                                                                    **n = 3,700**                          
  Anxiety                                                                                                                                                                                                     
      • Severe      30.2%                                                             7.7%                                                                             5.7 (3.4--9.5)                         \<0.001
      • Moderate    10.5%                                                             5.5%                                                                             3.0 (1.4--6.3)                         0.004
      • Mild/None   59.3%                                                             86.8%                                                                            Baseline                               
  Depression                                                                                                                                                                                                  
      • Severe      30.2%                                                             6.0%                                                                             7.8 (4.6--13.1)                        \<0.001
      • Moderate    9.3%                                                              4.3%                                                                             4.1 (1.9--9.1)                         \<0.001
      • Mild/None   60.5%                                                             89.7%                                                                            Baseline                               

\* There were some missing data for depression variables: 3--4 people within Nepal, Guatemala, and India across cases and controls, and 3 cases and 53 controls in Cameroon.

10.1371/journal.pone.0231563.t005

###### Association between anxiety and depression and functional difficulties in mobility.
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                    People with mobility functional difficulties (a lot or cannot do)   People without mobility functional difficulties (no difficulty/ some difficulty)   OR (95% CI) adjusted for age and sex   p-value
  ----------------- ------------------------------------------------------------------- ---------------------------------------------------------------------------------- -------------------------------------- ---------
  **Nepal**         **n = 79**                                                          **n = 3,903**                                                                      **n = 3,982**                          
  Anxiety                                                                                                                                                                                                         
      • Severe      10.1%                                                               1.0%                                                                               12.6 (5.4, 29.5)                       \<0.001
      • Moderate    21.5%                                                               4.1%                                                                               7.2 (4.0, 13.1)                        \<0.001
      • Mild/None   68.4%                                                               95.0%                                                                              Baseline                               
  Depression                                                                                                                                                                                                      
      • Severe      7.6%                                                                0.7%                                                                               14.2 (5.4, 37.1)                       \<0.001
      • Moderate    29.1%                                                               4.4%                                                                               9.6 (5.5, 16.4)                        \<0.001
      • Mild/None   63.3%                                                               94.8%                                                                              Baseline                               
  **Guatemala**     **n = 214**                                                         **n = 7,387**                                                                      **n = 7,600**                          
  Anxiety                                                                                                                                                                                                         
      • Severe      34.1%                                                               5.3%                                                                               10.4 (7.3, 14.7)                       \<0.001
      • Moderate    24.3%                                                               21.1%                                                                              2.0 (1.4, 2.9)                         \<0.001
      • Mild/None   41.6%                                                               73.6%                                                                              Baseline                               
  Depression                                                                                                                                                                                                      
      • Severe      25.7%                                                               2.5%                                                                               13.9 (9.4, 20.6)                       \<0.001
      • Moderate    22.4%                                                               12.8%                                                                              2.7 (1.9, 3.8)                         \<0.001
      • Mild/None   51.9%                                                               84.8%                                                                              Baseline                               
  **India**         **n = 111**                                                         **n = 2,221**                                                                      **n = 2,332**                          
  Anxiety                                                                                                                                                                                                         
      • Severe      22.5%                                                               7.0%                                                                               4.0 (2.3, 6.9)                         \<0.001
      • Moderate    28.8%                                                               19.1%                                                                              1.8 (1.1, 2.9)                         0.02
      • Mild/None   48.7%                                                               73.8%                                                                              Baseline                               
  Depression                                                                                                                                                                                                      
      • Severe      22.5%                                                               5.2%                                                                               5.4 (3.1, 9.4)                         \<0.001
      • Moderate    23.4%                                                               15.8%                                                                              1.7 (1.0, 2.8)                         0.04
      • Mild/None   54.1%                                                               79.0%                                                                              Baseline                               
  **Cameroon**      **n = 87**                                                          **n = 1,505**                                                                      **n = 1,592**                          
  Anxiety                                                                                                                                                                                                         
      • Severe      17.2%                                                               5.2%                                                                               4.4 (2.3, 8.7)                         \<0.001
      • Moderate    32.2%                                                               25.2%                                                                              1.9 (1.2, 3.2)                         0.01
      • Mild/None   50.6%                                                               69.6%                                                                              Baseline                               
  Depression                                                                                                                                                                                                      
      • Severe      19.0%                                                               5.5%                                                                               4.5 (2.3, 8.8)                         \<0.001
      • Moderate    27.9%                                                               17.4%                                                                              2.5 (1.4, 4.3)                         0.001
      • Mild/None   53.2%                                                               77.2%                                                                              Baseline                               
  **Maldives**      **n = 166**                                                         **n = 3,534**                                                                      **n = 3,700**                          
  Anxiety                                                                                                                                                                                                         
      • Severe      25.9%                                                               7.4%                                                                               5.2 (3.4--7.9)                         \<0.001
      • Moderate    7.2%                                                                5.6%                                                                               2.0 (1.0--3.8)                         0.05
      • Mild/None   66.9%                                                               87.1%                                                                              Baseline                               
  Depression                                                                                                                                                                                                      
      • Severe      25.3%                                                               5.7%                                                                               7.7 (4.9--12.1)                        \<0.001
      • Moderate    6.6%                                                                4.3%                                                                               3.2 (1.6--6.6)                         0.001
      • Mild/None   68.1%                                                               90.0%                                                                              Baseline                               

\* There were some missing data for depression variables: 3--6 people within Nepal, Guatemala, and India across cases and controls, and 8 cases and 41 controls in Cameroon.

In Nepal and Guatemala, there was strong evidence of an association between functional difficulties in hearing and severe anxiety and depression ([Table 3](#pone.0231563.t003){ref-type="table"}). In India, the Maldives and Cameroon there was no evidence of an association between hearing difficulties and severe anxiety or depression. Moderate depression was only associated with hearing loss in Nepal, and moderate measures of depression or anxiety were unrelated to functional difficulties with hearing in the other settings.

Functional difficulties in vision were associated with severe anxiety and depression in all five settings ([Table 4](#pone.0231563.t004){ref-type="table"}). Additionally, functional vision difficulties were associated with moderate anxiety and depression in Nepal, the Maldives and Guatemala, and moderate depression in India, but not with anxiety in India or either mental health condition in Cameroon.

Mobility functional difficulties were associated with both moderate and severe depression and anxiety in all settings ([Table 5](#pone.0231563.t005){ref-type="table"}).

Several consistent patterns were observed across the types of functional difficulty (Tables [3](#pone.0231563.t003){ref-type="table"}--[5](#pone.0231563.t005){ref-type="table"}). In the multiple regression analysis, as the absolute numbers of individuals with functional difficulties were small, the adjusted odds ratios (OR) often had wide confidence intervals. In most settings and types of functional difficulties, the point estimate of the association of the three functional difficulties with anxiety and depression was greater than 1, with depression generally slightly greater than anxiety (difference not significant at the p = 0.05 level). The magnitude of association of the functional difficulty with 'high' levels of anxiety or depression compared to with low levels/none, was always greater than the association with 'medium' levels compared to low/none. More evidence of associations for anxiety and depression with all functional impairment types were seen in Nepal and Guatemala, compared to Cameroon and India, although the latter were smaller studies. The estimates for the Maldives generally fell in the middle range.

Discussion {#sec013}
==========

This study provides evidence from five low and middle-income settings that the presence of a physical or sensory functional difficulties is associated with both anxiety and depression. This association was observed in all five studies, except for with hearing loss in India, the Maldives and Cameroon, where no clear association was found. For all settings, there was a stronger association of all types of functional difficulties with high levels of anxiety and depression than with moderate levels.

Our findings of increased odds of depression and anxiety in those with functional difficulties was generally consistent with the previous literature, mainly from high income settings \[[@pone.0231563.ref002]--[@pone.0231563.ref004]\]. Few studies were identified from low and middle-income countries, but these too reported an association between depression and/or anxiety with functional difficulties \[[@pone.0231563.ref022], [@pone.0231563.ref023], [@pone.0231563.ref029]\]. We noted a stronger association of severe mental health conditions with other functional difficulties, compared to more moderate conditions. Similarly, the England psychiatric morbidity survey showed a trend of stronger association of functional difficulties in mobility, vision and hearing and anxiety/depression as the severity of the anxiety/depression increased \[[@pone.0231563.ref017]\]. Our analysis did not examine the association of mental health conditions with multiple functional difficulties or the severity of those difficulties. However, a large study among people aged over 65 in China identified that, among those with motor disabilities, having other co-morbid disabilities and having more severe motor disability were both associated with a higher risk of psychiatric co-morbidity (cognitive, affective, or behavioral disorders) \[[@pone.0231563.ref005]\].

The explanation of the differences in magnitude of the association between different settings seen is not clear, particularly the reason why weaker associations are seen where the overall prevalence of physical and sensory functional difficulties is higher. There may be a true difference in risk of poor mental health between the settings, for example associated with the opportunities available for disabled people or community attitude to disability. However, it may also be connected to cultural variation, in particular, a difference in likelihood of reporting functional difficulties or symptoms of anxiety and depression in the different settings. Another potential explanation is the option of 'some' within the Washington Group questions, and whether differences in translation could impact reported severities. For example, it is possible that people with a broader range of severity in their vision, hearing and mobility functional limitations were included in the "a lot/cannot do" group in Cameroon and India on account of the translation or other cultural factors, who may have been included in the "none/some" group in the other settings.

There are strengths and limitations to the study, in addition to those already outlined, which should be taken into account when interpreting the results. The main strengths to this study are i) that it included large, population-based data sets from five different countries, ii) the relatively uniform methodology enabled us to compare different countries and iii) the comprehensive questions allowed us to assess several functional domains at the same time. The survey methodology has been validated and all had high response rates (≥82%). Our main hypothesis was that physical and sensory difficulties can lead to anxiety and depression, potentially as a result of pain, reduced perceived control, activity restriction, impact on financial circumstances and changing social relationships \[[@pone.0231563.ref002], [@pone.0231563.ref017]\]. However, it is also possible that the presence of anxiety and depression may change individuals' perception and reporting of their physical and sensory functioning, and therefore may lead to a bias in the responses, as postulated by researchers in the past \[[@pone.0231563.ref018]\]. The potential for bias is a particular concern since the Washington group questions were used to measure both mental health and functional difficulties through self-report and do not include objective clinical criteria. However, our previous analyses have shown a relatively strong association of clinical and subjective criteria for the higher thresholds of the Washington Group questions \[[@pone.0231563.ref026], [@pone.0231563.ref028]\]. An additional weakness of this study is that it is not able to answer these questions of causation directly as it was cross-sectional rather than longitudinal, and limited adjustment for factors such as socio-economic status means that the associations may be influenced by (residual) confounding. Information was not collected on age at onset of the disability, which may be an important determinant of the impact on mental health. For instance, we could hypothesise that if onset occurs at a younger age then people would have had more time to adapt and therefore will present with fewer mental health consequences \[[@pone.0231563.ref030]\]. Furthermore, we did not consider the impact of the cause of disability--potentially traumatic injuries, as an example, may have more mental health impacts than those related to illness. The study also lacked qualitative data, which would have allowed the nature of these associations to be explored further.

Despite these limitations, it does appear that the prevalence of mental health conditions is linked to the presence of physical/sensory functional difficulties. Access to rehabilitation and mental health services is frequently poor in LMICs \[[@pone.0231563.ref019]\], and there are well documented barriers to healthcare access for individuals with a disability \[[@pone.0231563.ref031], [@pone.0231563.ref032]\]. The association of mental health and physical/sensory functional difficulties implies that there should be more integrated care between rehabilitation/specialist care and mental health services, and that general/primary healthcare services should be aware of comorbidities and multiple support requirements. Furthermore, there should potentially be routine assessment of depression/anxiety in people with physical and sensory functional difficulties. This initiative may involve training community health workers or rehabilitation staff to identify anxiety and depression among patients with physical and sensory impairments. Additionally, Mental Health and Psychosocial Services must be accessible to people with physical and sensory functional difficulties, which may involve adjustment in how, where or by whom the services are offered. These findings also have implications for the design of future studies. Morris' literature review commented that there is 'a tendency in research practice to deliberately exclude people with physical impairments if the focus of research is mental health difficulties', which would have implications on the generalisability of mental health research among those with physical and sensory impairments \[[@pone.0231563.ref002], [@pone.0231563.ref017], [@pone.0231563.ref018], [@pone.0231563.ref026], [@pone.0231563.ref028], [@pone.0231563.ref033]\]

Conclusion {#sec014}
==========

This evidence supports the need for ensuring a good awareness of mental ill health among those working with individuals with physical and sensory functional difficulties in LMICs. This implies that these practitioners must have the skills to identify anxiety and depression. Furthermore, mental health services must be available and accessible to patients with these conditions, which will likely require further programmatic scale-up in these LMIC settings.

Supporting information {#sec015}
======================

###### Individuals reporting aids or medication use for anxiety or depression.

(DOCX)
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Click here for additional data file.
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